Paper36768435
Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential.
McHenry PR and 1 other. Int J Mol Sci, 2023. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential. Papers, record 36768435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768435
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Humans | |
| Female | |
| Secretome | |
| Stromal Cells |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Research Scholar Grant | American Cancer Society | PubMed |
Source PubMed
References149
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31167491 | Nodal Facilitates Differentiation of Fibroblasts to Cancer-Associated Fibroblasts that Support Tumor Growth in Melanoma and Colorectal Cancer. | Cells | 2019 | https://conductscience.org/library/papers/31167491 | PubMed |
| 2 | 23536895 | TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis. | PLoS One | 2013 | https://conductscience.org/library/papers/23536895 | PubMed |
| 3 | 18316557 | Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18316557 | PubMed |
| 4 | 31084432 | Tocotrienols Modulate Breast Cancer Secretomes and Affect Cancer-Signaling Pathways in MDA-MB-231 Cells: A Label-Free Quantitative Proteomic Analysis. | Nutr Cancer | 2019 | https://conductscience.org/library/papers/31084432 | PubMed |
| 5 | 36559228 | CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36559228 | PubMed |
| 6 | 28647698 | Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival. | Cancer Genomics Proteomics | 2017 | https://conductscience.org/library/papers/28647698 | PubMed |
| 7 | 21898842 | Applying small molecule microarrays and resulting affinity probe cocktails for proteome profiling of mammalian cell lysates. | Chem Asian J | 2011 | https://conductscience.org/library/papers/21898842 | PubMed |
| 8 | 32430285 | Apolipoprotein(a), an enigmatic anti-angiogenic glycoprotein in human plasma: A curse or cure? | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32430285 | PubMed |
| 9 | 28604807 | Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer. | PLoS One | 2017 | https://conductscience.org/library/papers/28604807 | PubMed |
| 10 | 35096187 | Evaluating the Role of IL-1β in Transmigration of Triple Negative Breast Cancer Cells Across the Brain Endothelium. | Cell Mol Bioeng | 2022 | https://conductscience.org/library/papers/35096187 | PubMed |
| 11 | 29940241 | Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers. | Life Sci | 2018 | https://conductscience.org/library/papers/29940241 | PubMed |
| 12 | 35261806 | Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness. | Am J Cancer Res | 2022 | https://conductscience.org/library/papers/35261806 | PubMed |
| 13 | 25149155 | CD109 is a potential target for triple-negative breast cancer. | Tumour Biol | 2014 | https://conductscience.org/library/papers/25149155 | PubMed |
| 14 | 35196008 | Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models. | ACS Appl Mater Interfaces | 2022 | https://conductscience.org/library/papers/35196008 | PubMed |
| 15 | 25499743 | Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling. | Breast Cancer Res | 2014 | https://conductscience.org/library/papers/25499743 | PubMed |
| 16 | 35076579 | Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer. | Noncoding RNA | 2022 | https://conductscience.org/library/papers/35076579 | PubMed |
| 17 | 35140332 | Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases. | Oncogene | 2022 | https://conductscience.org/library/papers/35140332 | PubMed |
| 18 | 9714718 | Stimulatory effects of lipoprotein(a) and low-density lipoprotein on human umbilical vein endothelial cell migration and proliferation are partially mediated by fibroblast growth factor-2. | Biochim Biophys Acta | 1998 | https://conductscience.org/library/papers/9714718 | PubMed |
| 19 | 35626166 | GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35626166 | PubMed |
| 20 | 24377810 | Basal-like breast cancer: update on clinicopathologic, immunohistochemical, and molecular features. | Arch Pathol Lab Med | 2014 | https://conductscience.org/library/papers/24377810 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41974939 | Chromosomal instability promotes cell migration and invasion via EFEMP1 secretion into extracellular vesicles. | EMBO J | 2026 | https://conductscience.org/library/papers/41974939 | PubMed |
| 41870799 | Integrated single-cell and spatial mapping coupled with machine learning unveils core stemness landscapes and regulatory drivers in triple-negative breast cancer. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41870799 | PubMed |
| 41851715 | The Galectin-3-binding protein promotes angiogenesis in pancreatic cancer via simultaneous upregulation of VEGFA and direct HUVEC activation mediated by and VAMP5-STAT3. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41851715 | PubMed |
| 41018846 | A robust protocol for proteomic profiling of secreted proteins in conditioned culture medium. | Biol Methods Protoc | 2025 | https://conductscience.org/library/papers/41018846 | PubMed |
| 39450256 | Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/39450256 | PubMed |
| 39210220 | The treatment landscape of triple-negative breast cancer. | Med Oncol | 2024 | https://conductscience.org/library/papers/39210220 | PubMed |
| 38463784 | Single-cell RNA sequencing reveals distinct transcriptomic profiles and evolutionary patterns in lung cancer brain metastasis. | Heliyon | 2024 | https://conductscience.org/library/papers/38463784 | PubMed |
| 37375323 | Omics-Based Investigations of Breast Cancer. | Molecules | 2023 | https://conductscience.org/library/papers/37375323 | PubMed |
| 37174117 | Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37174117 | PubMed |
| 37108283 | The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108283 | PubMed |
| 36831218 | The Potential of PSMA as a Vascular Target in TNBC. | Cells | 2023 | https://conductscience.org/library/papers/36831218 | PubMed |
Genes108
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36768435
GET https://conductscience.org/api/papers/v1/36768435/references?page=2